Cargando…
HbA(1c) Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression
BACKGROUND: Long-term glycemic control reduces retinopathy risk, but transient worsening can occur with glucose control intensification. Glucagon-like peptide 1 receptor agonists (GLP-1RA) lower glucose, but the long-term impact on retinopathy is unknown. GLP-1RA cardiovascular outcome trials (CVOTs...
Autores principales: | Bethel, M. Angelyn, Diaz, Rafael, Castellana, Noelia, Bhattacharya, Indranil, Gerstein, Hertzel C., Lakshmanan, Mark C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783944/ https://www.ncbi.nlm.nih.gov/pubmed/33444163 http://dx.doi.org/10.2337/dc20-1815 |
Ejemplares similares
-
Estimating the effect of sulfonylurea on HbA(1c) in diabetes: a systematic review and meta-analysis
por: Hirst, J. A., et al.
Publicado: (2013) -
The bidirectional longitudinal association between depressive symptoms and HbA(1c): A systematic review and meta‐analysis
por: Beran, Magdalena, et al.
Publicado: (2021) -
Risk of lower limb amputation in diabetic patients using SGLT2 inhibitors versus DPP4 inhibitors or GLP-1 agonists: a meta-analysis of 2 million patients
por: Lu, Yang, et al.
Publicado: (2023) -
PPAR-alpha/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: A network meta-analysis
por: Zhang, Zhuo-Ya, et al.
Publicado: (2023) -
Malondialdehyde levels in diabetic retinopathy patients: a systematic review and meta-analysis
por: Jiang, Fanwen, et al.
Publicado: (2023)